DC260126
CAS No. 346692-04-4
DC260126( —— )
Catalog No. M20675 CAS No. 346692-04-4
DC260126 is a small-molecule antagonist of FFA1 (GPR40).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 51 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 63 | In Stock |
|
| 25MG | 137 | In Stock |
|
| 50MG | 211 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDC260126
-
NoteResearch use only, not for human use.
-
Brief DescriptionDC260126 is a small-molecule antagonist of FFA1 (GPR40).
-
DescriptionDC260126 is a small-molecule antagonist of FFA1 (GPR40) .
-
In VitroDC260126 reduces GTP-loading and ERK1/2 phosphorylation stimulated by linoleic acid in GPR40-CHO cells, suppresses palmitic acid potentiated glucose-stimulated insulin secretion, and negatively regulates GPR40 mRNA expression induced by oleic acid in Min6 cells.
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetGPR
-
RecptorGPR40
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number346692-04-4
-
Formula Weight307.38
-
Molecular FormulaC16H18FNO2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (325.33 mM)
-
SMILESCCCCc1ccc(NS(=O)(=O)c2ccc(F)cc2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Peng S Ting W Yuren Z et al. DC260126: A Small-Molecule Antagonist of GPR40 that Protects against Pancreatic β-Cells Dysfunction in db/db Mice[J]. PLoS ONE 2013 8(6):e66744-.
molnova catalog
related products
-
MBX2982
MBX-2982 is a selective, orally-available GPR119 agonist for the treatment of type 2 tiabetes.
-
AH 7614
AH 7614 is a selective and potent free fatty acid receptor 4 (FFA4/GPR120) antagonist.
-
NCRW0005-F05
NCRW0005-F05 is a potent agonist of orphan G-protein coupled receptor GPR139 with an IC 50 value of 0.21 μM. NCRW0005-F05 can be used to research diabetes, obesity and Parkinson's disease .
Cart
sales@molnova.com